» Articles » PMID: 32477938

Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases

Overview
Journal Front Oncol
Specialty Oncology
Date 2020 Jun 2
PMID 32477938
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The term "uterine smooth muscle tumor of uncertain malignant potential" (STUMP) indicates a rare tumor that cannot be classified as a benign leiomyoma or malignant leiomyosarcoma. In this study, we assessed the clinical characteristics, fertility, and oncologic outcomes of patients diagnosed as STUMP in 14 years. In addition, we analyzed the risk factors for recurrence in patients with STUMP. Medical records of STUMP patients at Peking Union Medical College Hospital (PUMCH) between January 2005 and June 2019 were reviewed and analyzed. Disease-free survival, age of diagnosis, tumor size, surgical procedure, pathology and immunohistochemistry, clinical characteristics, recurrence rate, and reproductive outcomes in the follow-up period were assessed. Univariate and multivariate analyses were performed to determine the prognostic factors. The median age was 42 years old (range: 21-63). Total hysterectomy with or without bilateral salpingo-oophorectomy was performed in 29/67 cases (43.3%), and myomectomy was performed in 38/67 cases (56.7%). Ten patients experienced recurrences, and all but two recurrences occurred within 5 years after the initial surgery. Only two of these recurrences were leiomyosarcoma. There were no deaths in the median follow-up period of 48.4 (range 2.6-170.2) months. There were no remarkable differences in location of tumor between the myomectomy and hysterectomy groups, but the patients in the myomectomy group were younger than those in the hysterectomy group. In univariate and multivariate analysis, mitosis on pathology was the only independent risk factor for recurrence. Expression of Ki-67, p53, and p16 was significantly higher in patients with recurrence. Seven of the 35 patients who attempted to conceive had successful pregnancies. The prognosis of STUMP was favorable and tumors with more than 10 mitoses per 10 high power field should be monitored closely. The surgical procedure was not an independent risk factor of recurrence, and myomectomy may be an acceptable option for patients wishing to preserve fertility.

Citing Articles

Primary leiomyosarcoma of the scalp: a case report and review of the literature.

Gao S, Liu P, Liu J, Yang W, Yang S Front Oncol. 2025; 15:1533114.

PMID: 40007995 PMC: 11850309. DOI: 10.3389/fonc.2025.1533114.


First Case Report of Uterine Leiomyosarcoma Diagnosed After Transcervical Fibroid Ablation.

Chronas D, Jorg I, Bolten K, Reich L, Toub D, Varga Z J Clin Med. 2025; 14(1.

PMID: 39797170 PMC: 11722006. DOI: 10.3390/jcm14010088.


Uterine smooth muscle tumors of uncertain malignant potential: a 13-year retrospective study.

Liu L, Xiao Z, Li Z, Zheng J, Xu X, Zhou H Front Oncol. 2024; 14:1458968.

PMID: 39575428 PMC: 11578816. DOI: 10.3389/fonc.2024.1458968.


Reproductive and oncologic outcomes in young women with uterine sarcoma undergoing fertility-sparing treatment: a systematic review.

Etrusco A, Agrifoglio V, Lagana A, Gliozheni E, Caringella A, Stanziano A Ther Adv Reprod Health. 2024; 18:26334941241271563.

PMID: 39351375 PMC: 11440568. DOI: 10.1177/26334941241271563.


Case report: Spontaneous rupture of leiomyosarcoma uteri 8 months after primary laparoscopic surgery of STUMP.

Bicanin-Ilic M, Ilic I, Dimitrijevic A, Mujkovic S, Jovic N, Rakic D Front Med (Lausanne). 2024; 11:1407546.

PMID: 38912336 PMC: 11192603. DOI: 10.3389/fmed.2024.1407546.


References
1.
Bell S, Kempson R, Hendrickson M . Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994; 18(6):535-58. View

2.
Hewedi I, Radwan N, Shash L . Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors. Diagn Pathol. 2012; 7:1. PMC: 3261803. DOI: 10.1186/1746-1596-7-1. View

3.
DallAsta A, Gizzo S, Musaro A, Quaranta M, Noventa M, Migliavacca C . Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence. Int J Clin Exp Pathol. 2015; 7(11):8136-42. PMC: 4270570. View

4.
Maltese G, Fontanella C, Lepori S, Scaffa C, Fuca G, Bogani G . Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features. Oncology. 2017; 94(1):1-6. DOI: 10.1159/000479818. View

5.
Ricci S, Stone R, Fader A . Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecol Oncol. 2017; 145(1):208-216. DOI: 10.1016/j.ygyno.2017.02.019. View